LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) › Capital ExpendituresLIFECORE BIOMEDICAL, INC. \DE\ (LFCR) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $5.19M2011: $6.68M2012: $5.37M2013: $8.88M2014: $14.89M2015: $17.51M2016: $39.70M2017: $23.00M2018: $33.59M2019: $44.73M2020: $12.21M2021: $19.26M2022: $26.23M2024: $18.39M2025: $13.41M$13.41M2010Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$13.41M-27.1%2024$18.39M—2022$26.23M+36.1%2021$19.26M+57.7%2020$12.21M-72.7%2019$44.73M+33.2%2018$33.59M+46.0%2017$23.00M-42.1%2016$39.70M+126.7%2015$17.51M+17.6%2014$14.89M+67.7%2013$8.88M+65.3%2012$5.37M-19.6%2011$6.68M+28.7%2010$5.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share